Gilead Sciences Inc (NASDAQ:GILD)

75.51
Delayed Data
As of Sep 21
 +0.68 / +0.91%
Today’s Change
64.27
Today|||52-Week Range
89.54
+5.40%
Year-to-Date

Today’s Trading

Previous close74.83
Today’s open74.79
Day’s range74.75 - 75.93
Volume9,578,716
Average volume (3 months)6,550,639
Market cap$97.9B
Data as of 4:00pm ET, 09/21/2018

Growth & Valuation

Earnings growth (last year)-64.69%
Earnings growth (this year)-25.50%
Earnings growth (next 5 years)-3.15%
Revenue growth (last year)-13.79%
P/E ratio44.9
Price/Sales3.62
Price/Book4.83

Competitors

 Today’s
change
Today’s
% change
BIIBBiogen+4.17+1.22%
AMGNAmgen0.000.00%
ILMNIllumina Inc+1.84+0.52%
TLRYTilray Inc-53.35-30.25%
Data as of 4:00pm ET, 09/21/2018

Financials

Next reporting dateOctober 30, 2018
EPS forecast (this quarter)$1.61
Annual revenue (last year)$26.1B
Annual profit (last year)$4.6B
Net profit margin17.71%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John F. Milligan
CFO, Principal Accounting Officer &
Executive VP
Robin L. Washington
Corporate headquarters
Foster City, California

Forecasts